Validation of Varian Clinac iX Model on 6 MV Photon Beam Using Fast Monte Carlo Simulation
DOI:
https://doi.org/10.26555/jiteki.v9i4.27075Keywords:
Monte Carlo, PDD, Dose profile, DPM, PENELOPEAbstract
Monte Carlo (MC) is widely recognized as the most accurate method for dosimetry analysis in radiotherapy due to its precision. However, successful MC dose calculation hinges upon the validation of the linac model employed in simulations. This study aims to verify the PRIMO model of the Varian Clinac iX and to determine the optimal initial electron energy. The comparison of one-dimensional dose distribution between simulations and measurements serves as the foundation for assessment. The Varian Clinac iX on 6 MV photon beam was meticulously modeled with the initial electron energies spanned from 5.2 to 5.8 MeV in increments of 0.2 MeV. The dose calculation were performed for a field size of 10 cm × 10 cm and a source-to-surface distance (SSD) of 100 cm. The Dose Planning Method (DPM) was adopted as the simulation engine for expedited MC simulation. A number of particle histories–approximately 4.0 × 108–were simulated, resulting in the generation of around 109 particles from the linac head. The investigation revealed that an initial electron energy of 5.8 MeV achieves good agreement with measurement by attaining the smallest difference in percentage depth dose (PDD) of about 0.98%. The lateral dose deviation of approximately 4.63% serves to validate the precision of the secondary collimator design. Additionally, a comparative analysis of DPM and PENELOPE for dose calculation was conducted. In contrast to the PENELOPE, the DPM speeds up simulation time by approximately 3.5 times, reduced statistical uncertainties to 0.59% and afford better accuracy in dose calculation. The result underscore the suitability of the PRIMO model for MC simulation for dose calculation, given its robust agreement with the measurements.Downloads
Published
2023-10-09
Issue
Section
Articles
License
Authors who publish with JITEKI agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution 4.0 International License